Creo Medical Group Past Earnings Performance

Past criteria checks 0/6

Creo Medical Group's earnings have been declining at an average annual rate of -18.9%, while the Medical Equipment industry saw earnings growing at 2% annually. Revenues have been growing at an average rate of 43.9% per year.

Key information

-18.9%

Earnings growth rate

-4.5%

EPS growth rate

Medical Equipment Industry Growth4.3%
Revenue growth rate43.9%
Return on equity-36.3%
Net Margin-85.5%
Next Earnings Update15 May 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How Creo Medical Group makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BST:1RC Revenue, expenses and earnings (GBP Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 2329-25420
31 Mar 2328-26430
31 Dec 2227-27440
30 Sep 2226-28450
30 Jun 2226-28470
31 Mar 2226-26440
31 Dec 2125-25420
30 Sep 2124-23380
30 Jun 2122-21340
31 Mar 2116-21310
31 Dec 209-20280
30 Sep 205-19240
30 Jun 200-17200
31 Mar 200-17200
31 Dec 190-16190
30 Jun 190-13160
31 Mar 190-12140
31 Dec 180-10120
31 Dec 170-8100
30 Sep 170-890
30 Jun 170-880
30 Jun 161-560
29 Feb 161-340
28 Feb 150-230
28 Feb 141-230

Quality Earnings: 1RC is currently unprofitable.

Growing Profit Margin: 1RC is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 1RC is unprofitable, and losses have increased over the past 5 years at a rate of 18.9% per year.

Accelerating Growth: Unable to compare 1RC's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 1RC is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-9.8%).


Return on Equity

High ROE: 1RC has a negative Return on Equity (-36.28%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.